Du, S.* ; Wisskirchen, K.* ; Zhang, K.* & Protzer, U. Correspondence on Editorial regarding "Genetically modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting". Clin. Mol. Hepatol. 31, e44-e47 (2024)
Wan, X.* et al. Genetically redirected HBV-specific T cells target HBsAg-positive hepatocytes and primary lesions in HBV-associated HCC. Clin. Mol. Hepatol. 30, 735-755 (2024)